Osamu Shiraishi

12PUBLICATIONS
0CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Carbon capture engineering (excl. sequestration)Wastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 30, 2025
Validity of using plastic bags to wrap the esophagus after the thoracic procedure during radical esophageal cancer surgery.

Masashi Kohda, Motohiro Imano, Hiroaki Kato

|May 20, 2025
Benefits of neoadjuvant chemotherapy: is the prognosis of ypN0 patients after neoadjuvant chemotherapy comparable to that of pN0 patients undergoing surgery alone?

Osamu Shiraishi, Koji Tanaka, Tomoki Makino

|Apr 28, 2025
Initial reduction of the primary tumor or lymph nodes: which is the better prognostic factor in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemotherapy followed by surgery?

Takaomi Hagi, Osamu Shiraishi, Masuhiro Terada

|May 15, 2024
Risk factors and prognosis for supraclavicular lymph node metastasis in patients with thoracic esophageal cancer. Distant or regional metastasis?

Osamu Shiraishi, Takaomi Hagi, Yoko Hiraki

|May 03, 2024
ASO Author Reflections: Tumor Response After the First Course of Neoadjuvant Chemotherapy Reflects Prognosis After Surgery in Patients with Esophageal Squamous Cell Carcinoma.

Takaomi Hagi, Osamu Shiraishi, Takushi Yasuda

|Apr 25, 2024
Utility of Initial Tumor Reduction as a Prognostic Factor in Esophageal Squamous Cell Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery : A Retrospective Cohort Study.

Takaomi Hagi, Osamu Shiraishi, Tomoya Nakanishi

Pageof 2

Frequent Collaborators